YeChun Ruan

Dr. YeChun Ruan

Department of Biomedical Engineering, The Hong Kong Polytechnic University, Kowloon, Hong Kong
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2016 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YZYifeng Zhang
Yifeng Zhang
JXJiankun Xu
Jiankun Xu
YRYeChun Ruan
YeChun Ruan
MYMei Kuen Yu
Mei Kuen Yu
MOMicheal O'LAughlin
Micheal O'LAughlin
LQLing Qin
Ling Qin

24 June 2012 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
YRYeChun Ruan
YeChun Ruan
JGJing Hui Guo
Jing Hui Guo
XLXinmei Liu
Xinmei Liu
RZRunju Zhang
Runju Zhang
LTLai Ling Tsang
Lai Ling Tsang
HCHsiao Chang Chan
Hsiao Chang Chan

15 July 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJing Hui Guo
Jing Hui Guo
HCHui Chen
Hui Chen
YRYeChun Ruan
YeChun Ruan
XZXue Lian Zhang
Xue Lian Zhang
XZXiao Hu Zhang
Xiao Hu Zhang
HCHsiao Chang Chan
Hsiao Chang Chan
The cause of insulin insufficiency remains unknown in many diabetic cases. Up to 50% adult patients with cystic fibrosis (CF), a disease caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR), develop CF-related diabetes (CFRD) with most patients exhibiting insulin insufficiency. Here we show that CFTR is a regulator of glucose-dependent electrical acitivities and insulin secretion in β-cells. We demonstrate that glucose elicited whole-cell currents, membrane depolarization, electrical bursts or action potentials, Ca2+oscillations and insulin secretion are abolished or reduced by inhibitors or knockdown of CFTR in primary mouse β-cells or RINm5F β-cell line, or significantly attenuated in CFTR mutant (DF508) mice compared with wild-type mice. VX-809, a newly discovered corrector of DF508 mutation, successfully rescues the defects in DF508 β-cells. Our results reveal a role of CFTR in glucose-induced electrical activities and insulin secretion in β-cells, shed light on the pathogenesis of CFRD and possibly other idiopathic diabetes, and present a potential treatment strategy.

17 June 2012 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
HCHui Chen
Hui Chen
YRYeChun Ruan
YeChun Ruan
WXWen Ming Xu
Wen Ming Xu
JCJing Chen
Jing Chen
HCHsiao Chang Chan
Hsiao Chang Chan
The cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-activated Cl− and HCO3− conducting channel, mutations of which are known to be associated with male infertility. However, the underlying mechanisms remain elusive. Literature databases were searched for papers on the topics related to CFTR and male fertility and infertility with relevant keywords. Unpublished data from authors' laboratory were also included for analysis. Clinical evidence shows increased mutation frequency or reduced CFTR expression in men with congenital bilateral absence of vas deferens (CBAVD) or sperm abnormalities, such as azoospermia teratospermia and oligoasthenospermia. Studies on primary rodent Sertoli cells and germ cells, as well as testes from CFTR knockout mice or a cryptorchidism model, yield findings indicating the involvement of CFTR in spermatogensis through the HCO3−/sAC/cAMP/CREB(CREM) pathway and the NF-κB/COX-2/PGE2 pathway. Evidence also reveals a critical role of CFTR in sperm capacitation by directly or indirectly mediating HCO3− entry that is essential for capacitation. CFTR is emerging as a versatile player with roles in mediating different signaling pathways pertinent to various reproductive processes, in addition to its long-recognized role in electrolyte and fluid transport that regulates the luminal microenvironment of the male reproductive tract. CFTR is a key regulator of male fertility, a defect of which may result in different forms of male infertility other than CBAVD. It would be worthwhile to further investigate the potential of developing novel diagnostic and contraceptive methods targeting CFTR.

14 May 2009 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
HCHsiao Chang Chan
Hsiao Chang Chan
YRYeChun Ruan
YeChun Ruan
QHQiong He
Qiong He
Minhui ChenMinhui Chen
Minhui Chen
HCHui Chen
Hui Chen
ZZZhen Zhou
Zhen Zhou
The cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel regulated by cAMP‐dependent phosphorylation, which is expressed in epithelial cells of a wide variety of tissues including the reproductive tracts. Mutations in the gene encoding CFTR cause cystic fibrosis, a common genetic disease in Caucasian populations with a multitude of clinical manifestations including infertility/subfertility in both sexes. However, the physiological role of CFTR in reproduction and its involvement in the pathogenesis of reproductive diseases remain largely unknown. This review discusses the role of CFTR in regulating fluid volume and bicarbonate secretion in the reproductive tracts and their importance in various reproductive events. We also discuss the contribution of CFTR dysfunction to a number of pathological conditions. The evidence presented is consistent with an important role of CFTR in reproductive health and disease, suggesting that CFTR might be a potential target for the diagnosis and treatment of reproductive diseases including infertility.

23 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAnie Azroyan
Anie Azroyan
VCVirna Cortez-Retamozo
Virna Cortez-Retamozo
RBRichard Bouley
Richard Bouley
RLRachel Liberman
Rachel Liberman
YRYeChun Ruan
YeChun Ruan
SBSylvie Breton
Sylvie Breton
Uncontrolled inflammation is one of the leading causes of kidney failure. Pro-inflammatory responses can occur in the absence of infection, a process called sterile inflammation. Here we show that the purinergic receptor P2Y14 (GPR105) is specifically and highly expressed in collecting duct intercalated cells (ICs) and mediates sterile inflammation in the kidney. P2Y14 is activated by UDP-glucose, a damage-associated molecular pattern molecule (DAMP) released by injured cells. We found that UDP-glucose increases pro-inflammatory chemokine expression in ICs as well as MDCK-C11 cells, and UDP-glucose activates the MEK1/2-ERK1/2 pathway in MDCK-C11 cells. These effects were prevented following inhibition of P2Y14 with the small molecule PPTN. Tail vein injection of mice with UDP-glucose induced the recruitment of neutrophils to the renal medulla. This study identifies ICs as novel sensors, mediators and effectors of inflammation in the kidney via P2Y14.